We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLR icon
2176
Fluor
FLR
$6.54B
$386K ﹤0.01%
+12,501
New +$430K
LEU icon
2177
Centrus Energy
LEU
$3.14B
$386K ﹤0.01%
+12,000
New +$461K
HUBCW icon
2178
CALL
Hub Cyber Security Warrant 2/27/28
HUBCW
$164K
$386K ﹤0.01%
+296,672
New +$40.2K
NABL icon
2179
N-able
NABL
$844M
$385K ﹤0.01%
+29,200
New +$323K
IDYA icon
2180
IDEAYA Biosciences
IDYA
$3.43B
$383K ﹤0.01%
+27,903
New +$465K
ORIC icon
2181
Oric Pharmaceuticals
ORIC
$1.17B
$383K ﹤0.01%
+67,206
New +$351K
IPSC icon
2182
Century Therapeutics
IPSC
$364M
$383K ﹤0.01%
110,316
+52,818
+92% +$232K
RGP icon
2183
Resources Connection
RGP
$140M
$382K ﹤0.01%
22,374
+4,828
+28% +$84.7K
QURE icon
2184
uniQure
QURE
$2.78B
$382K ﹤0.01%
+18,944
New +$397K
ADMA icon
2185
ADMA Biologics
ADMA
$2.02B
$380K ﹤0.01%
+114,900
New +$397K
EPM icon
2186
Evolution Petroleum
EPM
$133M
$380K ﹤0.01%
60,166
-3,713
-6% -$23.8K
SMMT icon
2187
Summit Therapeutics
SMMT
$10.2B
$375K ﹤0.01%
214,033
-408,833
-66% -$1.12M
TCBX icon
2188
Third Coast Bancshares
TCBX
$738M
$374K ﹤0.01%
23,838
-19,202
-45% -$344K
VLRS
2189
Controladora Vuela Compania de Aviacion
VLRS
$869M
$373K ﹤0.01%
30,018
ARKOW
2190
CALL
DELISTED
ARKO Corp Warrant
ARKOW
$373K ﹤0.01%
43,959
ATRO icon
2191
Astronics
ATRO
$3.21B
$372K ﹤0.01%
+33,437
New +$373K
IHI icon
2192
iShares US Medical Devices ETF
IHI
$3.17B
$371K ﹤0.01%
6,864
-47,036
-87% -$2.5M
PINE
2193
Alpine Income Property Trust
PINE
$336M
$369K ﹤0.01%
21,942
-59,835
-73% -$1.11M
PCYO icon
2194
Pure Cycle
PCYO
$255M
$369K ﹤0.01%
39,069
-58,432
-60% -$538K
DIBS icon
2195
1stdibs.com
DIBS
$148M
$369K ﹤0.01%
92,878
-96,833
-51% -$492K
WASH icon
2196
Washington Trust Bancorp
WASH
$748M
$368K ﹤0.01%
+10,618
New +$448K
KORE.WS
2197
CALL
DELISTED
KORE Group Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
KORE.WS
$366K ﹤0.01%
300,000
RSI icon
2198
Rush Street Interactive
RSI
$3.17B
$364K ﹤0.01%
+117,130
New +$450K
MITA
2199
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$364K ﹤0.01%
35,510
-54,494
-61% -$553K
TUSK icon
2200
Mammoth Energy Services
TUSK
$122M
$363K ﹤0.01%
86,135
-76,593
-47% -$456K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.